<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Hytn Innovations Inc — News on 6ix</title>
<link>https://6ix.com/company/hytn-innovations-inc</link>
<description>Latest news and press releases for Hytn Innovations Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 30 Apr 2026 21:01:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/hytn-innovations-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836837678dffbe2df1694b6.webp</url>
<title>Hytn Innovations Inc</title>
<link>https://6ix.com/company/hytn-innovations-inc</link>
</image>
<item>
<title>HYTN Successfully Exports GMP-Manufactured Vape Cartridges</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-successfully-exports-gmp-manufactured-vape-cartridges</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-successfully-exports-gmp-manufactured-vape-cartridges</guid>
<pubDate>Thu, 30 Apr 2026 21:01:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market. The shipment included 1,0</description>
</item>
<item>
<title>HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-announces-proposed-spin-out-of-bpc-157-peptide-drug-development-business</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-announces-proposed-spin-out-of-bpc-157-peptide-drug-development-business</guid>
<pubDate>Thu, 23 Apr 2026 21:01:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, April 23, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN) (OTC Pink: HYTNF) (FSE: 85W0) ("HYTN" or the "Company") announces that its Board of Directors has approved the spin-out of an internally developed peptide drug development business into a dedicated new company ("SpinCo"). As part of the proposed spin-out, SpinCo is expected to complete a concurrent financing to fund the next phase of its development and to pursue a public listing on the Canadian Sec</description>
</item>
<item>
<title>HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-introduces-hard-remediation-to-gmp-processing-services-releases-product-in-germany</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-introduces-hard-remediation-to-gmp-processing-services-releases-product-in-germany</guid>
<pubDate>Fri, 17 Apr 2026 21:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, April 17, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce the commercial launch of Hermetic Autogenous Remediation™ (“HARd”) as a service offering for qualified dried cannabis flower programs. HARd is HYTN’s proprietary remediation process for dried cannabis flower, develope</description>
</item>
<item>
<title>HYTN Successfully Releases Cannabis Products in Germany and Accepts Reorder</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-successfully-releases-cannabis-products-in-germany-and-accepts-reorder</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-successfully-releases-cannabis-products-in-germany-and-accepts-reorder</guid>
<pubDate>Fri, 27 Mar 2026 22:46:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, March 27, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis, is pleased to announce that wholesale cannabis products previously exported to Germany during the prior quarter have now been successfully released for sale in the German market. The release follows completion of require</description>
</item>
<item>
<title>HYTN Appoints Fabian Monaco to Board of Directors</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-appoints-fabian-monaco-to-board-of-directors-1</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-appoints-fabian-monaco-to-board-of-directors-1</guid>
<pubDate>Fri, 20 Mar 2026 21:30:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, March 20, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in cannabis, is pleased to announce the appointment of Mr. Fabian Monaco to its Board of Directors, effective immediately. Mr. Monaco is an accomplished technology entrepreneur, investor, and operator with a proven history of building and scaling high-growth businesses. He brings extensive experience ac</description>
</item>
<item>
<title>HYTN Announces Extension of Marketing Program</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-announces-extension-of-marketing-program</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-announces-extension-of-marketing-program</guid>
<pubDate>Mon, 02 Mar 2026 22:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in cannabis, announces, further to its news release on January 9th 2026, that it is extending its engagement of MCS Market Communication Service GmbH (“MCS”) to provide certain marketing and communications services. The engagement is expected to commence on March 3, 2026, and continue for a period of ap</description>
</item>
<item>
<title>HYTN Announces Engagement of Marketing and Communications Services Provider</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-announces-engagement-marketing-communications-220000435</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-announces-engagement-marketing-communications-220000435</guid>
<pubDate>Fri, 09 Jan 2026 22:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Jan. 09, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in cannabis, announces that it has engaged MCS Market Communication Service GmbH (“MCS”) to provide certain marketing and communications services. The engagement is expected to commence on January 12, 2026, and continue for a period of approximately 60 days, or until the allocated budget is exhausted, su</description>
</item>
<item>
<title>HYTN Welcomes U.S. Executive Order Initiating Cannabis Reclassification to Schedule III</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-welcomes-u-executive-order-220100362</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-welcomes-u-executive-order-220100362</guid>
<pubDate>Thu, 18 Dec 2025 22:01:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical-grade cannabis manufacturer, acknowledges the announcement by the United States administration issuing an executive order directing federal agencies to initiate the reclassification of cannabis to a Schedule III controlled substance under U.S. federal law. The executive order directs the relevant federal authorities to advance th</description>
</item>
<item>
<title>HYTN Secures Cannabis Drug Licence, Advancing Prescription Drug Pathway for Cannabinoid-Based Medicines</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-secures-cannabis-drug-licence-120000036</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-secures-cannabis-drug-licence-120000036</guid>
<pubDate>Mon, 14 Jul 2025 12:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, July 14, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce it has received a Cannabis Drug Licence (CDL) from Health Canada. The CDL, issued July 2, 2025, complements HYTN’s existing Drug Establishment Licence (DEL) and federally issued Cannabis Licences, placing the Company among a limited group of organizations authorized t</description>
</item>
<item>
<title>HYTN Receives Initial International Purchase Order for GMP Vape Cartridges</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-receives-initial-international-purchase-120000576</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-receives-initial-international-purchase-120000576</guid>
<pubDate>Wed, 11 Jun 2025 12:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, June 11, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has received its first purchase order and import permit for Good Manufacturing Practices (GMP) cannabis vape cartridges (the “Products” or “Vapes”). This milestone follows the Company’s January 21 news release detailing a collaboration agreement with SNDL to d</description>
</item>
<item>
<title>HYTN Receives GMP Certificates for The United States, Bermuda and Israel</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-receives-gmp-certificates-united-000000813</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-receives-gmp-certificates-united-000000813</guid>
<pubDate>Thu, 03 Apr 2025 00:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has received digital Good Manufacturing Practices (GMP) certificates (the “Certificates”) from Health Canada, confirming the GMP compliance of its Kelowna-based manufacturing facility. Issued under HYTN’s Drug Establishment Licence (“DEL”), these Certificates</description>
</item>
<item>
<title>HYTN Secures Strategic Supply Agreements and Qualifies 4000kg of Cannabis for German Market</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-secures-strategic-supply-agreements-000000667</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-secures-strategic-supply-agreements-000000667</guid>
<pubDate>Sat, 29 Mar 2025 00:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, March 28, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or the "Company"), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce it has entered into strategic supply agreements (the “Agreements”) and successfully completed vendor qualification with two cannabis cultivators under its Good Manufacturing Practice (GMP) system qualifying a minimum of 4000 kg of cannabis for the German market. This</description>
</item>
<item>
<title>HYTN Launches GMP Stability Program and Validates Vape Cartridges for International Markets</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-launches-gmp-stability-program-003000188</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-launches-gmp-stability-program-003000188</guid>
<pubDate>Wed, 19 Feb 2025 00:30:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or the "Company"), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce the launch of its Good Manufacturing Practice (GMP) Stability Program and the validation of its cannabis vape cartridges for international distribution. This initiative builds upon HYTN’s January 21, 2025, announcement of its strategic partnership with SNDL Inc. to de</description>
</item>
<item>
<title>HYTN and A1 Cannabis Announce Collaboration Agreements to Scale Production of Cannabis Products</title>
<link>https://6ix.com/company/hytn-innovations-inc/news/hytn-a1-cannabis-announce-collaboration-003000158</link>
<guid isPermaLink="true">https://6ix.com/company/hytn-innovations-inc/news/hytn-a1-cannabis-announce-collaboration-003000158</guid>
<pubDate>Tue, 18 Feb 2025 00:30:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Feb. 17, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has entered into a comprehensive collaboration (the “Collaboration”) with A1 Cannabis Inc. (“A1”), owner of Summit Cannabis Beverages ("Summit"). Through the Collaboration, the Company and A1 seek to enhance operational efficiency and expand both</description>
</item>
</channel>
</rss>